HIV/dendritic cell interaction: consequences in the pathogenesis of HIV infection.

AIDS Rev

Host-Pathogen Interaction Unit, Instituto de Investigação do Medicamento (iMed.ULisboa); Centro de Patogénese Molecular, Unidade dos Retrovírus e Infecções Associadas (CPM-URIA); Instituto de Medicina Molecular (IMM). Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal.

Published: August 2015

Dendritic cells are professional antigen-presenting cells and key elements of both innate and adaptive immunity. Tissues like skin and mucosal epithelium, more exposed to the environment, are particularly rich in dendritic cells. Given that HIV is mainly transmitted through mucosal surfaces, the cellular mechanisms governing the initial interactions between HIV and dendritic cells are crucial for establishing systemic infection in a new host. Upon HIV/dendritic cell interaction, viral particles carried by exposed dendritic cells are transmitted to activated CD4+ T-cells during the antigen presentation process. Such dendritic cell/T-cell transmission of HIV plays an important role in the viral dissemination and immune dysregulation associated with HIV infection, subverting the bridge between innate and adaptive immune responses. Thus, defining how HIV interacts with dendritic cells remains a critical area of research, with downstream implications in the knowledge of pathogenic mechanisms, transmission, vaccine development, and molecular targets for therapeutic intervention. In this review we will, therefore, delve into the mechanisms involved in HIV/dendritic cell interactions that govern viral persistence, cellular trafficking, transmission and restriction, compiling the present knowledge on these subjects and attempting to postulate how some uncertain pathways may shape up and intertwine.

Download full-text PDF

Source

Publication Analysis

Top Keywords

dendritic cells
20
hiv/dendritic cell
12
cell interaction
8
hiv infection
8
innate adaptive
8
hiv
6
dendritic
6
cells
6
interaction consequences
4
consequences pathogenesis
4

Similar Publications

Background: Alzheimer's disease (AD) is a devastating form of dementia, and its prevalence is rising as human lifespan increases. Our lab created the AD-BXD mouse model, which expresses AD mutations across a genetically diverse reference panel (BXD), to identify factors that confer resilience to cognitive decline in AD. This model mimics key characteristics of human AD including variation in age of onset and severity of cognitive decline.

View Article and Find Full Text PDF

Background: Genetic studies indicate a causal role for microglia, the innate immune cells of the central nervous system (CNS), in Alzheimer's disease (AD). Despite the progress made in identifying genetic risk factors, such as CD33, and underlying molecular changes, there are currently limited treatment options for AD. Based on the immune-inhibitory function of CD33, we hypothesize that inhibition of CD33 activation may reverse microglial suppression and restore their ability to resolve inflammatory processes and mitigate pathogenic amyloid plaques, which may be neuroprotective.

View Article and Find Full Text PDF

Background: The impact of probiotics as gut and immunological modulator in restoring gut microbial balance and immune cells expression have generated much attention in the health sector. Its inhibitory effect on bacterial translocation and associated neural inflammatory processes has been reported. However, there is scarcity of data on its neuroprotective impact against neuroinflammation-associated neurodegeneration and memory impairment.

View Article and Find Full Text PDF

Background: Understanding the fundamental differences between the human and pre-human brain is a prerequisite for designing meaningful models and therapies for AD. Expressed CHRFAM7A, a human restricted gene with carrier frequency of 75% in the human population predicts profound translational significance.

Method: The physiological role of CHRFAM7A in human brain is explored using multiomics approach on 600 post mortem human brain tissue samples (ROSMAP).

View Article and Find Full Text PDF

Dementia Care Research and Psychosocial Factors.

Alzheimers Dement

December 2024

Westport, CT, USA.

Background: A 73-year-old female with a 3 year history of Alzheimer's disease was treated within the protocol of The Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study (ACIST), an IRB approved clinical study registered with clinicaltrials.gov NCT03724136.

Method: The procedure consists of bone marrow aspiration, cell separation using an FDA cleared class 2 device, and intravenous and intranasal administration of the stem cell fraction.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!